Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-21 Sale | 2025-03-24 9:00 pm | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 48,563 | $1.35 | $65,560 | 115,636 (Direct) | View |
| 2025-03-21 Sale | 2025-03-24 9:00 pm | ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer | 11,563 | $1.35 | $15,610 | 8,437 (Direct) | View |
| 2025-03-21 Sale | 2025-03-24 9:00 pm | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 75,418 | $1.35 | $101,814 | 216,442 (Indirect Direct) | View |
| 2025-03-21 Sale | 2025-03-24 9:00 pm | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 33,545 | $1.35 | $45,286 | 140,045 (Direct) | View |
| 2025-03-21 Sale | 2025-03-24 9:00 pm | ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer | 13,161 | $1.35 | $17,767 | 42,333 (Direct) | View |
| 2025-03-24 Purchase | 2025-03-24 5:00 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 1,800,000 | $1.4 | $2,520,000 | 44,168,717 (Indirect) | View |
| 2025-02-14 Purchase | 2025-02-19 6:00 pm | ATAI Life Sciences N.V. | ATAI | Apeiron Investment Group Ltd. Angermayer Christian 10% Owner | 10,835,718 | $2.1 | $22,755,008 | 42,354,517 (Indirect) | View |
| 2024-09-26 Sale | 2024-09-27 8:00 pm | COMPASS Pathways plc | CMPS | ATAI Life Sciences N.V. ATAI Life Sciences AG 10% Owner | 2,660,000 | $6.05 | $16,093,000 | 6,905,774 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | JOHNSON SABRINA MARTUCCI Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Hoffman John Francis Director | 206,000 | $0 | 206,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Fischer Laurent Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Braunstein Scott Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-26 Option Award | 2025-06-27 5:31 pm | N/A 2035-06-26 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 103,000 | $0 | 103,000 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 4:38 pm | N/A 2035-06-02 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 131,698 | $0 | 131,698 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-19 7:29 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-19 7:29 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer | 32,500 | $0 | 55,494 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-19 7:29 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 175,000 | $0 | 291,860 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-19 7:29 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Kirpekar Sahil Chief Business Officer | 100,000 | $0 | 164,199 (Direct) | View |
| 2025-03-14 Exercise | 2025-03-19 7:29 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 100,000 | $0 | 173,590 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-06 09:10 am | N/A 2035-03-03 | ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer | 757,915 | $0 | 757,915 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-06 09:06 am | N/A 2035-03-03 | ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer | 757,915 | $0 | 757,915 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:28 pm | N/A 2035-03-03 | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 757,915 | $0 | 757,915 (Direct) | View |
| 2025-01-07 Option Award | 2025-01-10 4:15 pm | N/A 2035-01-06 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 2,340,000 | $0 | 2,340,000 (Direct) | View |
Ownership | 2025-01-10 4:15 pm | N/A N/A | ATAI Life Sciences N.V. | ATAI | Short Glenn Frank Chief Scientific Officer | 0 | $0 | 1,611,626 (Direct) | View |
Ownership | 2025-01-10 4:15 pm | N/A 2032-01-03 | ATAI Life Sciences N.V. | ATAI | Craig Kevin James Chief Medical Officer | 0 | $0 | 1,077,027 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 4:30 pm | N/A 2035-01-01 | ATAI Life Sciences N.V. | ATAI | Kochendoerfer Gerd Chief Operating Officer | 1,450,000 | $0 | 1,450,000 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:32 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 624,000 | $0 | 624,000 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Johnson Anne Nagengast Chief Financial Officer | 441,568 | $0 | 441,568 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Rao Srinivas See Remarks | 2,857,360 | $0 | 2,857,360 (Direct) | View |
| 2024-10-04 Option Award | 2024-10-04 4:30 pm | N/A 2030-08-20 | ATAI Life Sciences N.V. | ATAI | Brand Florian See Remarks | 4,978,800 | $0 | 4,978,800 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Auerbach Michael Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Angermayer Christian Director 10% Owner | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Braunstein Scott Director | 206,000 | $0 | 206,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Smiley Andrea Heslin Director | 103,000 | $0 | 103,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Fischer Laurent Director | 206,000 | $0 | 206,000 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-14 5:00 pm | N/A 2034-06-13 | ATAI Life Sciences N.V. | ATAI | Kalali Amir H Director | 103,000 | $0 | 103,000 (Direct) | View |